Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,219.00
+18.00 (1.50%)
Jul 1, 2026, 1:20 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 20.77 billion as of June 30, 2026. Its market cap has decreased by -42.89% in one year.
Market Cap
20.77B
Enterprise Value
19.75B
Revenue
2.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,219.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 20.77B, a decrease of -76.98%. That is a compound annual growth rate of -52.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 20.77B | -27.69% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 119.54B |
| Amicogen | 103.28B |
| MedPacto | 96.31B |
| Prestige BioPharma | 80.89B |
| CG Invites | 78.28B |
| ENCell | 78.20B |
| iNtRON Biotechnology | 74.77B |
| IMB Dx | 49.48B |